A detailed history of River Front Investment Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, River Front Investment Group, LLC holds 9,408 shares of ABT stock, worth $1.07 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,408
Previous 9,106 3.32%
Holding current value
$1.07 Million
Previous $1.03 Million 5.51%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 28, 2024

BUY
$100.73 - $112.44 $30,420 - $33,956
302 Added 3.32%
9,408 $977,000
Q2 2024

Aug 05, 2024

BUY
$100.73 - $112.44 $30,420 - $33,956
302 Added 3.32%
9,408 $978,000
Q1 2024

Aug 28, 2024

BUY
$109.52 - $120.96 $78,854 - $87,091
720 Added 8.59%
9,106 $1.03 Million
Q1 2024

May 02, 2024

BUY
$109.52 - $120.96 $78,854 - $87,091
720 Added 8.59%
9,106 $1.04 Million
Q3 2023

Aug 28, 2024

BUY
$95.53 - $114.62 $13,087 - $15,702
137 Added 1.66%
8,386 $812,000
Q3 2023

Nov 07, 2023

BUY
$95.53 - $114.62 $14,711 - $17,651
154 Added 1.87%
8,386 $812,000
Q2 2023

Aug 28, 2024

SELL
$100.78 - $112.29 $116,804 - $130,144
-1,159 Reduced 12.32%
8,249 $899,000
Q4 2022

Feb 15, 2023

BUY
$95.06 - $111.52 $26,997 - $31,671
284 Added 3.57%
8,232 $903,000
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $109,145 - $126,369
-1,128 Reduced 12.43%
7,948 $769,000
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $306 - $370
3 Added 0.03%
9,076 $986,000
Q1 2022

May 05, 2022

SELL
$114.02 - $139.04 $77,419 - $94,408
-679 Reduced 6.96%
9,073 $1.07 Million
Q2 2021

Aug 09, 2021

BUY
$105.79 - $124.53 $1.03 Million - $1.21 Million
9,752 New
9,752 $1.13 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track River Front Investment Group, LLC Portfolio

Follow River Front Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Front Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Front Investment Group, LLC with notifications on news.